GlassScriptPhysician profile
Rochelle P Dyer
NPI 1487619896
$6,137.52
in general payments reported to CMS, 2019-2025
39 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,971 · 2022: $739 · 2023: $1,083 · 2024: $1,149 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,392 · Education: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,392.45 |
| Education | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,199.91 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $890.52 | 2021 | |
| Novo Nordisk INC | $645.70 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $466.18 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $387.19 | 2021-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $366.11 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $224.32 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.28 | 2021-2025 | Jardiance |
| Corcept Therapeutics | $151.73 | 2024 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $150.48 | 2021-2025 | Trintellix |
| Amarin Pharma, INC. | $139.63 | 2021-2022 | |
| Axsome Therapeutics, INC. | $100.13 | 2024-2025 | Auvelity |
| Exact Sciences Corporation | $98.70 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $93.87 | 2021-2024 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $92.80 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rochelle Dyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.